Clinical Trial Provides Lifesaving Treatment for Breast Cancer Patients
Dr. Sylvia Adams’ immunotherapy research provided early access to a then-experimental treatment. The success of the trial testing pembrolizumab (Keytruda) has saved many lives and led to the FDA-approval of the drug for more than 12 types of cancer treatment.
Read More